Cefepime-tazobactam: A promising therapeutic option

被引:0
|
作者
Panchatcharam, S. N. [1 ]
Ramasubramanian, V. [1 ]
Gopalakrishnan, R. [1 ]
Ghafur, A. [1 ]
Thirunarayan, M. [1 ]
机构
[1] Apollo Hosp, Madras 600006, Tamil Nadu, India
关键词
D O I
10.1016/j.ijid.2012.05.681
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:E470 / E471
页数:2
相关论文
共 50 条
  • [41] Targeted inhibition of angiogenesis suggests a promising therapeutic option in Histiocytic Sarcoma
    Reitter, S.
    Bauer, F.
    Jaeger, G.
    Linkesch, W.
    Langner, S.
    ONKOLOGIE, 2010, 33 : 178 - 179
  • [42] Targeting IAPs in Childhood Acute Lymphoblastic Leukemia A Promising Therapeutic Option?
    Meyer, M.
    Zinngrebe, J.
    Debatin, K-M
    Meyer, L-H
    ANNALS OF HEMATOLOGY, 2017, 96 : S72 - S72
  • [43] Antisense oligonucleotide: A promising therapeutic option to beat COVID-19
    Quemener, Anais M.
    Galibert, Marie-Dominique
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2022, 13 (04)
  • [44] Comparative Study of Piperacillin/Tazobactam and Cefepime in Cancer Patients with Febrile Neutropenia
    Wi, Y. M.
    Chung, D. R.
    Song, J. H.
    Peck, K. R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E401 - E401
  • [45] Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime
    Rutter, W. Cliff
    Cox, Jessica N.
    Martin, Craig A.
    Burgess, Donna R.
    Burgess, David S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (02)
  • [47] Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model
    VanScoy, Brian D.
    Tenero, David
    Turner, Simon
    Livermore, David M.
    McCauley, Jennifer
    Conde, Haley
    Bhavnani, Sujata M.
    Rubino, Christopher M.
    Ambrose, Paul G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [48] A Comparison Between Cefepime and Piperacillin-Tazobactam in the Management of Septic Shock
    Ross, Robert C.
    Rosen, Abbie N.
    Tran, Kenneth K.
    Smith, Katharyn L.
    Franck, Andrew J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [49] Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime
    Chanderraj, Rishi
    Admon, Andrew J.
    He, Ying
    Nuppnau, Mark
    Albin, Owen R.
    Prescott, Hallie C.
    Dickson, Robert P.
    Sjoding, Michael W.
    JAMA INTERNAL MEDICINE, 2024, 184 (07) : 769 - 777
  • [50] Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults
    Chanderraj, Rishi
    Dickson, Robert P.
    Sjoding, Michael W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (08):